Koers Grey Cloak Tech Inc OTC Bulletin Board
Aandelen
US3978451082
Farmaceutische producten
Omzet 2022 | 2,25 mln. 2,09 mln. | Omzet 2023 | 2,49 mln. 2,31 mln. | Marktkapitalisatie | 21,27 mln. 19,73 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | -2 mln. -1,86 mln. | EV/omzet 2022 | 6,37 x |
Nettoschuld 2022 | 528K 490K | Nettoschuld 2023 | 1,11 mln. 1,03 mln. | EV/omzet 2023 | 9 x |
K/w-verhouding 2022 |
-13,9
x | K/w-verhouding 2023 |
-8,49
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 26,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Duke Pitts
CEO | Chief Executive Officer | 64 | 28-09-18 |
William Bossung
FOU | Founder | 65 | 19-12-14 |
Robert Madden
DFI | Director of Finance/CFO | 52 | 01-03-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
William Bossung
FOU | Founder | 65 | 19-12-14 |
Duke Pitts
CEO | Chief Executive Officer | 64 | 28-09-18 |
Bill Croyle
BRD | Director/Board Member | 72 | 24-09-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,25% | 6,3 mld. | |
-15,08% | 4,53 mld. | |
-6,70% | 3,29 mld. | |
+5,47% | 3,2 mld. | |
+0,76% | 2,63 mld. | |
+47,75% | 1,97 mld. | |
-5,08% | 1,74 mld. | |
+2,05% | 1,69 mld. | |
-7,08% | 1,64 mld. |